Microvascular Therapeutics receives funds from Commercialization Readiness Program
MVT
Apr 11, 2022
0 min read
top of page
Search
Recent Posts
See AllExperienced pathologist, biotechnology entrepreneur, and life sciences investor will advise MVT on scientific and medical development
University of Utah researchers use MVT-101 phase-shift nanobubbles with focused ultrasound and MRI to confirm treatment location
bottom of page
Comments